Marvin Traub Associates will move closer to reaching its goal of raising $1 million this year to support bladder cancer research and increase awareness about the disease with a fund-raiser at Beautique in New York City on Tuesday.
This story first appeared in the July 9, 2014 issue of WWD. Subscribe Today.
The event is in partnership with Beltology, which has created a custom, limited-edition Pin Down Bladder Cancer belt. Proceeds from selling the belt and donations will benefit the Memorial Sloan-Kettering Bladder Cancer Research Fund.
“Representing the fourth most common cancer in men and fifth overall, bladder cancer is wide-spread, yet the research, awareness and treatment for this disease is vastly under-funded, receiving 10 to 20 times less funding than other common tumor cancers,” said Mortimer Singer, chief executive officer of Traub, who is spearheading the campaign. “Through our initiative, Pin Down Bladder Cancer, we are hoping to close that gap and elevate much-needed awareness of the disease.”
Traub’s efforts are in memory of Marvin Traub, the late founder of the company and former Bloomingdale’s chairman and ceo, and Maria Floyd, the late wife of World Golf Hall of Fame golfer Raymond Floyd. Her daughter, Christina Floyd Di Donna, is a member of the Pin Down Bladder Cancer board. July is Bladder Cancer Awareness Month.
Singer said men account for 80 percent of bladder cancer cases and that they often initially mistake symptoms for kidney stones. According to Singer, the company’s campaign charter is being amended to expand the beneficiaries. Also, a bracelet is in production to raise more funds, said Singer, who cited the $1 million goal.
“The limited-edition PDBC belt honors an esteemed retail veteran and a cause that is close to our hearts,” said Andrew Heffernan, ceo and founder of the six-month-old Beltology, which specializes in Italian-inspired stretch woven belts.
With 72,000 new cases nationally each year, and 15,000 deaths, bladder cancer affects approximately 500,000 people in the U.S. alone and is the most expensive cancer to treat on a per-patient basis. All proceeds raised from the Pin Down Bladder Cancer initiatives support Memorial Sloan-Kettering Cancer Center’s bladder cancer Translational Science Program. The translational science studies focus on the development of early detection strategies to improve more timely diagnosis and a molecular characterization effort designed to identify the critical pathways driving the growth of bladder cancer cells.